Kilitch Drugs (India) informs about certificate

17 Jul 2023 Evaluate

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Kilitch Drugs (India) has informed that it enclosed the Certificate received from Link Intime India, the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2023.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

351.30 3.40 (0.98%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.